Skip to main content
. 2014 Dec 25;54(7):1210–1219. doi: 10.1093/rheumatology/keu438

Table 4.

Multivariate regression analysis between BASMIlin and other clinical and demographic variables at year 5a

BASMIlin (dependent variable)
Parameter estimate (s.e.) t-value P-value
Intercept 0.852 (0.47) 1.82 0.07
Age, years 0.046 (0.01) 3.99 0.0001
BASFI 0–10 cm VAS 0.44 (0.06) 6.75 <0.0001
R2 = 0.44
Adjusted R2 = 0.43

aAnalysis is for the population who completed 5 years of adalimumab treatment. BASMIlin: linear BASMI.